论文部分内容阅读
Colorectal cancer(CRC)is the second most frequent malignant disease in Europe.Every year,412 000people are diagnosed with this condition,and 207 000patients die of it.In 2003,recommendations forscreening programs were issued by the Council of the European Union(EU),and these currently serve as thebasis for the preparation of European guidelines forCRC screening.The manner in which CRC screening iscarried out varies significantly from country to countrywithin the EU,both in terms of organization and thescreening test chosen.A screening program of onesort or another has been implemented in 19 of 27 EUcountries.The most frequently applied method is testing stool for occult bleeding(fecal occult blood test,FOBT).In recent years,a screening colonoscopy hasbeen introduced,either as the only method(Poland)orthe method of choice(Germany,Czech Republic).
Colorectal cancer (CRC) is the second most frequent malignant disease in Europe. Every year, 412 000 people are diagnosed with this condition, and 207 000 patients die of it. In 2003, recommendations forscreening programs were issued by the Council of the European Union (EU ), and these currently serve as thebasis for the preparation of European guidelines forCRC screening.The manner in which CRC screening iscarried out significantly significant from country to countrywithin the EU, both in terms of organization and the screening test chosen. A screening program of onesort or another has been implemented in 19 of 27 EU countries. the most frequently applied method is testing stool for occult bleeding (fecal occult blood test, FOBT) .In recent years, a screening colonoscopy hasbeen introduced, either as the only method (Poland) orthe method of choice (Germany, Czech Republic).